IL17RB and breast neoplasm: For examples, Furuta et al found that 13 out of 69 (18.8%) clinic sections from human breast tumors showed IL-17RB expression (Furuta et al., 2011), whereas Huang et al found that 38 out of 179 (21%, based on data presented in Fig. 6B in the paper) showed membranous staining of IL-17RB in the tumor cells (Huang et al., 2014).